Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2022
Title: Fahao Wu: Innovator in Biocatalytic Synthesis
Introduction
Fahao Wu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biocatalysis, particularly in the synthesis of pharmaceutical compounds. His innovative methods have the potential to enhance the efficiency of drug production.
Latest Patents
Fahao Wu holds a patent for a "Method for biocatalytic synthesis of Sitagliptin and intermediate thereof." This patent outlines a method that involves the biocatalytic synthesis of Sitagliptin, a medication used to treat type 2 diabetes. The patent details the compounds of Formula (I) and Formula (II), along with a polypeptide that catalyzes the conversion of these compounds. Additionally, it includes a nucleic acid encoding the polypeptide, a vector, and a cell that comprises the nucleic acid. This innovative approach also describes methods for producing Sitagliptin and its intermediates.
Career Highlights
Throughout his career, Fahao Wu has worked with various companies, including China Fortune Way Company and Nanjing Redwood Fine Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in chemical synthesis and biocatalysis.
Collaborations
Fahao Wu has collaborated with notable colleagues such as Wen Wen Yang and Gang Li. These partnerships have likely fostered a productive environment for innovation and research in the field of biocatalysis.
Conclusion
Fahao Wu's contributions to biocatalytic synthesis represent a significant advancement in pharmaceutical manufacturing. His patented methods and collaborative efforts highlight his role as an influential inventor in the industry.